Transjugular intrahepatic portosystemic shunt for portal hypertension in hepatocellular carcinoma with portal vein tumor thrombus
Cardiovascular and Interventional Radiology Aug 11, 2017
Qiu B, et al. – Researchers sought to evaluate utility and safety of transjugular intrahepatic portosystemic shunt (TIPS) for treatment of symptomatic portal hypertension in hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). TIPS was recommended as a safe and feasible treatment option for symptomatic portal hypertension in HCC with PVTT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
